EMA committee recommends approval of Astellas' zolbetuximab in combo with chemotherapy to treat advanced gastric and GEJ ...
Astellas Pharma Inc. announced that on July 26, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the approval of zolbetuximab in the European Union. Zolbetuximab, …